Cite
HARVARD Citation
Singh, K. et al. (n.d.). 789. Viral and Immunologic biomarkers of COVID-19 improve risk stratification and identify patients most likely to benefit from therapy with remdesivir. Open forum infectious diseases. p. . [Online].